http://orcid.org/0000-0002-9613-1712
References
- Practice CoO. Committee opinion no. 529: placenta accreta. Obstet Gynecol 2012;120:207.
- Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458–61.
- Tantbirojn P, Crum C, Parast M. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta 2008;29:639–45.
- Belfort MA, Committee P, Medicine SfM F. Placenta accreta. Am J Obstet Gynecol 2010;203:430–9.
- Lin T-M, Halbert SP, Kiefer D, et al. Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 1974;118:223–36.
- Laursen LS, Overgaard MT, Søe R, et al. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 2001;504:36–40.
- Alfthan H, Schröder J, Fraser R, et al. Choriogonadotropin and its beta subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem 1988;34:1758–62.
- Dugoff L. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes. Obstet Gynecol 2010;115:1052–61.
- Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol 2010;8:102.
- Shi Q, Lei Z, Rao CV, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 1993;132:1387–95.
- Costa SL, Proctor L, Dodd JM, et al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta 2008;29:1034–40.
- Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol 2006;108:573–81.
- Comstock CH, Love JJ, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004;190:1135–40.
- Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol 2010;116:835–42.
- Ong CY, Liao AW, Spencer K, et al. First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000;107:1265–70.
- D'Antonio F, Rijo C, Thilaganathan B, et al. Association between first‐trimester maternal serum pregnancy‐associated plasma protein‐A and obstetric complications. Prenat Diagn 2013;33:839–47.
- Zelop C, Nadel A, Frigoletto FD, Jr, et al. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1992;80:693–4.
- Kupferminc MJ, Tamura RK, Wigton TR, et al. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993;82:266–9.
- Hung T-H, Shau W-Y, Hsieh C-C, et al. Risk factors for placenta accreta. Obstet Gynecol 1999;93:545–50.
- Dreux S, Salomon LJ, Muller F, et al. Second‐trimester maternal serum markers and placenta accreta. Prenat Diagn 2012;32:1010–2.
- Desai N, Krantz D, Roman A, et al. Elevated first trimester PAPP-a is associated with increased risk of placenta accreta. Prenat Diagn 2014;34:159–62.
- Lyell D, Faucett A, Baer R, et al. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J Perinatol 2015;35:570–4.